Variant report
Variant | nsv945348 |
---|---|
Chromosome Location | chr1:228173369-228186556 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:14)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:14 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:228182608..228184218-chr1:228185823..228188577,2 | K562 | blood: | |
2 | chr1:228185172..228187867-chr1:228295198..228298113,3 | MCF-7 | breast: | |
3 | chr1:228185587..228188986-chr1:228190632..228193211,3 | MCF-7 | breast: | |
4 | chr1:228174620..228176417-chr1:228182023..228184650,2 | MCF-7 | breast: | |
5 | chr1:228185813..228188454-chr1:228247740..228249945,2 | MCF-7 | breast: | |
6 | chr1:228180647..228182707-chr1:228268126..228270057,2 | K562 | blood: | |
7 | chr1:228185727..228187297-chr1:228352308..228354949,2 | K562 | blood: | |
8 | chr1:228182718..228186056-chr1:228186655..228189573,4 | K562 | blood: | |
9 | chr1:228185399..228187182-chr1:228263997..228265663,2 | K562 | blood: | |
10 | chr1:228182608..228184218-chr1:228185823..228188577,2 | K562 | blood: | |
11 | chr1:228174620..228176417-chr1:228182023..228184650,2 | MCF-7 | breast: | |
12 | chr1:228184851..228186852-chr1:228326702..228329457,2 | K562 | blood: | |
13 | chr1:228184192..228186220-chr1:228191479..228194171,2 | MCF-7 | breast: | |
14 | chr1:228183425..228185730-chr1:228191246..228193322,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000143774 | chromatin interactions |
ENSG00000162910 | chromatin interactions |
ENSG00000181873 | chromatin interactions |
ENSG00000203684 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538340973 | chr1:228173828-228173829 | ZNF genes & repeats Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs553389156 | chr1:228173831-228173832 | ZNF genes & repeats Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs571714601 | chr1:228173837-228173838 | ZNF genes & repeats Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs542167445 | chr1:228173867-228173868 | ZNF genes & repeats Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556042088 | chr1:228173888-228173889 | ZNF genes & repeats Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs574237799 | chr1:228173963-228173964 | ZNF genes & repeats Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs17621519 | chr1:228173981-228173982 | ZNF genes & repeats Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs562940101 | chr1:228173992-228173993 | ZNF genes & repeats Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs533505973 | chr1:228174006-228174007 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
10 | rs544216837 | chr1:228174048-228174049 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
11 | rs545527866 | chr1:228174051-228174052 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
12 | rs367603466 | chr1:228174052-228174053 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562503113 | chr1:228174061-228174062 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
14 | rs189219991 | chr1:228174110-228174111 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
15 | rs143682337 | chr1:228174117-228174118 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181582966 | chr1:228174148-228174149 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531484764 | chr1:228174197-228174198 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2527618 | chr1:228174198-228174199 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558042333 | chr1:228180072-228180073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs573441343 | chr1:228180131-228180132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs113288732 | chr1:228180139-228180140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570870832 | chr1:228180143-228180144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192725893 | chr1:228180147-228180148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs11577983 | chr1:228180192-228180193 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs34917140 | chr1:228180194-228180195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs575751578 | chr1:228180227-228180228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs544722301 | chr1:228180244-228180245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538477891 | chr1:228180248-228180249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs369748914 | chr1:228180251-228180252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs562943255 | chr1:228180252-228180253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs533381091 | chr1:228180301-228180302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs551784101 | chr1:228180378-228180379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs560473350 | chr1:228180389-228180390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs139732106 | chr1:228180415-228180416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs143654817 | chr1:228180444-228180445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs147181082 | chr1:228180469-228180470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs537997015 | chr1:228180486-228180487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs112226226 | chr1:228180488-228180489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs558057061 | chr1:228180495-228180496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs549483553 | chr1:228180553-228180554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs141669172 | chr1:228180585-228180586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs183420289 | chr1:228180595-228180596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs538281539 | chr1:228180605-228180606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs553329769 | chr1:228180630-228180631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs573526426 | chr1:228180659-228180660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs139788278 | chr1:228180660-228180661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs115061303 | chr1:228180665-228180666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs574175448 | chr1:228180676-228180677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs149795202 | chr1:228180684-228180685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs2262292 | chr1:228180753-228180754 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Autism | 14699429 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Fumarase deficiency | 21572526 | CNVD |
Autism | 17483303 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 17060936 | CNVD |
Myelofibrosis | 22110671 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:228173800-228174000 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
2 | chr1:228173800-228174200 | ZNF genes & repeats | Aorta | Aorta |
3 | chr1:228180000-228180400 | Enhancers | Placenta | Placenta |
4 | chr1:228180400-228182600 | Weak transcription | Placenta | Placenta |
5 | chr1:228182000-228183000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr1:228182600-228182800 | Enhancers | Placenta | Placenta |
7 | chr1:228182800-228183000 | Bivalent Enhancer | Placenta | Placenta |